Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
IVZ Stock Summary
Top 10 Correlated ETFs
IVZ
In the News

Invesco Ltd. (IVZ) Q4 2022 Earnings Call Transcript
Invesco Ltd. (NYSE:IVZ ) Q4 2022 Earnings Conference Call January 24, 2022 9:00 AM ET Company Participants Greg Ketron – Head-Investor Relations Marty Flanagan – President and Chief Executive Officer Allison Dukes – Chief Financial Officer Conference Call Participants Glenn Schorr – Evercore Brian Bedell – Deutsche Bank Dan Fannon – Jefferies Brennan Hawken – UBS Craig Siegenthaler – Bank of America Alex Blostein – Goldman Sachs Bill Katz – Credit Suisse Patrick Davitt – Autonomous Research Mike Cyprys – Morgan Stanley Mike Brown – KBW Operator Welcome to Invesco's Fourth Quarter Earnings Conference Call.

Invesco (IVZ) Tops Q4 Earnings and Revenue Estimates
Invesco (IVZ) delivered earnings and revenue surprises of 8.33% and 4.37%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Invesco (IVZ) Q4 Earnings & Revenues Beat, AUM Balance Down
Lower operating expenses support Invesco's (IVZ) Q4 earnings, while a decline in revenues and AUM balance poses undermining factors.

3 Asset Management Stocks Set to Pull Off Earnings Beat in Q4
Amid challenging operating environment and bearish investor sentiments, asset managers - Artisan Partners (APAM), Ameriprise (AMP) and Invesco (IVZ) - are set to outpace estimates in Q4.

Activist Investors Make A Run At 9 Companies — Can You Score Too?
Fed-up activist investors are making a run for S&P 500 companies like Disney. Could this be the push needed to drive better returns?

Meet The 5 Unlucky Investors Who Loaded Up On Year's Worst Stocks
Few investors can hit all the year's best S&P 500 stocks. But some were unlucky enough to own big stakes of the worst.

Invesco (IVZ) October AUM Rises 2.8% on Favorable Markets
Invesco (IVZ) records a 2.8% sequential rise in preliminary assets under management for October 2022.

Invesco Ltd. (IVZ) Q3 2022 - Earnings Call Transcript
Invesco Ltd. (NYSE:IVZ ) Q3 2022 Earnings Conference Call October 25, 2022 9:00 AM ET Company Participants Greg Ketron - Head of Investor Relations Marty Flanagan - President and Chief Executive Officer Allison Dukes - Chief Financial Officer Conference Call Participants Brian Bedell - Deutsche Bank Brennan Hawken - UBS Glenn Schorr - Evercore Ken Worthington - JPMorgan Dan Fannon - Jefferies William Katz - Credit Suisse Michael Cyprys - Morgan Stanley Craig Siegenthaler - Bank of America Patrick Davitt - Autonomous Research Operator Welcome to Invesco's Third Quarter Earnings Conference Call [Operator Instructions].

Invesco (IVZ) Stock Dips on Q3 Earnings Miss, AUM Balance Down
Invesco (IVZ) records a decline in revenues and expenses in the third quarter of 2022.

Invesco (IVZ) Q3 Earnings and Revenues Miss Estimates
Invesco (IVZ) delivered earnings and revenue surprises of -20.93% and 2.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
IVZ Financial details
IVZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 12.6 | 12.89 | 13.97 | 13.37 | 14.9 | |
Net income per share | 2.75 | 2.14 | 1.57 | 1.66 | 3.52 | |
Operating cash flow per share | 3.35 | 2.01 | 2.55 | 2.68 | 2.33 | |
Free cash flow per share | 3.08 | 1.76 | 2.27 | 2.43 | 2.09 | |
Cash per share | 6.15 | 4.38 | 24.01 | 23.12 | 4.64 | |
Book value per share | 21.24 | 20.8 | 31.66 | 31.26 | 33.48 | |
Tangible book value per share | 1.97 | -0.96 | -3.54 | -3.08 | 0.12 | |
Share holders equity per share | 21.24 | 20.8 | 31.66 | 31.26 | 33.48 | |
Interest debt per share | 17.03 | 18.78 | 19.3 | 20.12 | 21.19 | |
Market cap | 15.02B | 7.67B | 7.72B | 9.46B | 10.05B | |
Enterprise value | 19.37B | 13.5B | 14.33B | 16.87B | 17.62B | |
P/E ratio | 13.32 | 8.68 | 11.21 | 12.42 | 6.17 | |
Price to sales ratio | 2.91 | 1.44 | 1.26 | 1.54 | 1.46 | |
POCF ratio | 10.96 | 9.25 | 6.91 | 7.69 | 9.32 | |
PFCF ratio | 11.93 | 10.56 | 7.78 | 8.48 | 10.37 | |
P/B Ratio | 1.73 | 0.89 | 0.56 | 0.66 | 0.65 | |
PTB ratio | 1.73 | 0.89 | 0.56 | 0.66 | 0.65 | |
EV to sales | 3.75 | 2.54 | 2.34 | 2.74 | 2.56 | |
Enterprise value over EBITDA | 12.06 | 9.7 | 11.59 | 12.44 | 7.16 | |
EV to operating cash flow | 14.13 | 16.28 | 12.84 | 13.71 | 16.34 | |
EV to free cash flow | 15.39 | 18.58 | 14.44 | 15.12 | 18.17 | |
Earnings yield | 0.08 | 0.12 | 0.09 | 0.08 | 0.16 | |
Free cash flow yield | 0.08 | 0.09 | 0.13 | 0.12 | 0.1 | |
Debt to equity | 0.79 | 0.89 | 0.6 | 0.63 | 0.63 | |
Debt to assets | 0.72 | 0.71 | 0.64 | 0.59 | 0.51 | |
Net debt to EBITDA | 2.71 | 4.19 | 5.35 | 5.46 | 3.07 | |
Current ratio | 1.13 | 1.07 | 0.22 | 0.3 | 1.01 | |
Interest coverage | 13.47 | 10.81 | 5.96 | 7.12 | 18.88 | |
Income quality | 1.22 | 0.94 | 1.62 | 1.62 | 0.66 | |
Dividend Yield | 0.03 | 0.06 | 0.08 | 0.06 | 0.05 | |
Payout ratio | 0.42 | 0.56 | 0.95 | 0.78 | 0.33 | |
Sales general and administrative to revenue | 0.43 | 0.44 | 0.46 | 0.48 | 0.45 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.26 | 0.3 | 0.4 | 0.44 | 0.49 | |
Capex to operating cash flow | -0.08 | -0.12 | -0.11 | -0.09 | -0.1 | |
Capex to revenue | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | |
Capex to depreciation | -0.96 | -0.72 | -0.7 | -0.57 | -0.53 | |
Stock based compensation to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
Graham number | 36.28 | 31.65 | 33.47 | 34.14 | 51.51 | |
ROIC | 0.08 | 0.07 | 0.03 | 0.03 | 0.06 | |
Return on tangible assets | 0.05 | 0.04 | 0.03 | 0.04 | 0.1 | |
Graham Net | -46.49 | -47.42 | -31.29 | -22.42 | -28.77 | |
Working capital | 1.87B | 967.1M | -10.46B | -6.76B | 21.5M | |
Tangible asset value | 806.2M | -397M | -1.55B | -1.41B | 57.5M | |
Net current asset value | -6.08B | -7.82B | -22.07B | -18.81B | -12.79B | |
Invested capital | 0.79 | 0.89 | 0.6 | 0.63 | 0.63 | |
Average receivables | 1.29B | 966.05M | 1.11B | 1.03B | 1.22B | |
Average payables | 334.5M | 316.6M | 381.75M | 348.9M | 330.7M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 109.48 | 62.24 | 71.07 | 60.94 | 74.67 | |
Days payables outstanding | 76 | 69.44 | 88.53 | 70.44 | 59.68 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.33 | 5.86 | 5.14 | 5.99 | 4.89 | |
Payables turnover | 4.8 | 5.26 | 4.12 | 5.18 | 6.12 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.13 | 0.1 | 0.05 | 0.05 | 0.11 | |
Capex per share | -0.27 | -0.25 | -0.28 | -0.25 | -0.24 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-22 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 3.78 | 3.81 | 3.55 | 3.35 | 3.16 | |
Net income per share | 0.84 | 1.05 | 0.56 | 0.39 | 0.52 | |
Operating cash flow per share | 1.3 | -0.01 | 1.07 | 0.27 | 1.08 | |
Free cash flow per share | 1.24 | -0.08 | 1.07 | 0.2 | 0.94 | |
Cash per share | 6.94 | 4.63 | 4.2 | 4.42 | 2.68 | |
Book value per share | 32.55 | 33.45 | 32.43 | 33.11 | 32.61 | |
Tangible book value per share | -0.85 | 0.12 | 2.07 | -0.06 | -0.08 | |
Share holders equity per share | 32.55 | 33.45 | 32.43 | 33.11 | 32.61 | |
Interest debt per share | 20.14 | 21.01 | 0.05 | 18.46 | 17.62 | |
Market cap | 11.17B | 10.67B | 9.94B | 7.36B | 6.26B | |
Enterprise value | 18.17B | 18.23B | 8.92B | 14.63B | 13.07B | |
P/E ratio | 7.17 | 5.49 | 9.67 | 10.22 | 6.62 | |
Price to sales ratio | 6.38 | 6.05 | 6.1 | 4.81 | 4.33 | |
POCF ratio | 18.59 | -2.88K | 20.2 | 59.82 | 12.73 | |
PFCF ratio | 19.43 | -271.38 | 20.2 | 81.91 | 14.58 | |
P/B Ratio | 0.74 | 0.69 | 0.67 | 0.49 | 0.42 | |
PTB ratio | 0.74 | 0.69 | 0.67 | 0.49 | 0.42 | |
EV to sales | 10.38 | 10.34 | 5.47 | 9.56 | 9.04 | |
Enterprise value over EBITDA | 30.13 | 26.41 | 21.62 | 45.97 | 33.52 | |
EV to operating cash flow | 30.23 | -4.93K | 18.12 | 118.87 | 26.57 | |
EV to free cash flow | 31.6 | -463.84 | 18.12 | 162.77 | 30.45 | |
Earnings yield | 0.03 | 0.05 | 0.03 | 0.02 | 0.04 | |
Free cash flow yield | 0.05 | 0 | 0.05 | 0.01 | 0.07 | |
Debt to equity | 0.62 | 0.63 | 0 | 0.56 | 0.54 | |
Debt to assets | 0.52 | 0.51 | 0.44 | 0.48 | 0.47 | |
Net debt to EBITDA | 11.61 | 10.96 | -2.48 | 22.84 | 17.47 | |
Current ratio | 1.19 | 1.01 | 0 | 0.9 | 1.01 | |
Interest coverage | 20.08 | 21.95 | 16.28 | 13.36 | 18.83 | |
Income quality | 1.54 | -0.01 | 1.92 | 0.68 | 2.08 | |
Dividend Yield | 0.01 | 0.01 | 0 | 0.02 | 0.02 | |
Payout ratio | 0.35 | 0.28 | 0 | 0.8 | 0.61 | |
Sales general and administrative to revenue | 0.45 | 0.45 | 0.46 | 0.48 | 0.44 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.49 | 0.49 | 0.53 | 0.52 | 0.53 | |
Capex to operating cash flow | -0.04 | 9.62 | 0 | -0.27 | -0.13 | |
Capex to revenue | -0.01 | -0.02 | 0 | -0.02 | -0.04 | |
Capex to depreciation | -0.51 | -0.71 | 0 | -0.67 | -1.31 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0 | 0.02 | 0.02 | |
Graham number | 24.81 | 28.1 | 20.2 | 17.15 | 19.49 | |
ROIC | 0.02 | 0.02 | 0 | 0.01 | 0.01 | |
Return on tangible assets | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 | |
Graham Net | -27.94 | -28.73 | -23.59 | -25.41 | -25.98 | |
Working capital | 721M | 21.5M | 0 | -252.5M | 19.1M | |
Tangible asset value | -392.8M | 57.5M | 951.7M | -25.8M | -38.7M | |
Net current asset value | -12.49B | -12.79B | -10.84B | -12.22B | -11.65B | |
Invested capital | 0.62 | 0.63 | 0 | 0.56 | 0.54 | |
Average receivables | 1.06B | 1.15B | 0 | 957.55M | 879.8M | |
Average payables | 1.37B | 822.45M | 0 | 1.34B | 1.33B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 63.33 | 71.98 | 0 | 60.88 | 54.77 | |
Days payables outstanding | 264.64 | 61.35 | 0 | 299.02 | 284.97 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.42 | 1.25 | 0 | 1.48 | 1.64 | |
Payables turnover | 0.34 | 1.47 | 0 | 0.3 | 0.32 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.03 | 0.03 | 0.02 | 0.01 | 0.02 | |
Capex per share | -0.06 | -0.08 | 0 | -0.07 | -0.14 |
IVZ Frequently Asked Questions
What is Invesco Ltd. stock symbol ?
Invesco Ltd. is a US stock , located in Atlanta of Ga and trading under the symbol IVZ
Is Invesco Ltd. buy or a sell ?
7 stock analysts have 7 predictions with a medium analyst target price of $25.43. The lowest prediction is $23 and the highest is $33
What is IVZ stock prediction ?
What is Invesco Ltd. stock quote today ?
Invesco Ltd. stock price is $20.04 today.
Is Invesco Ltd. stock public?
Yes, Invesco Ltd. is a publicly traded company.